Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling
Open Access
- 29 November 2007
- journal article
- Published by Springer Science and Business Media LLC in BMC Biochemistry
- Vol. 8 (1), 25
- https://doi.org/10.1186/1471-2091-8-25
Abstract
Cancer, like other diseases accompanied by strong metabolic disorders, shows characteristic effects on cell turnover rate, activity of modifying enzymes and DNA/RNA modifications, resulting also in elevated amounts of excreted modified nucleosides. For a better understanding of the impaired RNA metabolism in breast cancer cells, we screened these metabolites in the cell culture supernatants of the breast cancer cell line MCF-7 and compared it to the human mammary epithelial cells MCF-10A. The nucleosides were isolated and analyzed via 2D-chromatographic techniques: In the first dimension by cis-diol specific boronate affinity extraction and subsequently by reversed phase chromatography coupled to an ion trap mass spectrometer. Besides the determination of ribonucleosides, additional compounds with cis-diol structure, deriving from cross-linked biochemical pathways, like purine-, histidine- and polyamine metabolism were detected. In total, 36 metabolites were identified by comparison of fragmentation patterns and retention time. Relation to the internal standard isoguanosine yielded normalized area ratios for each identified compound and enabled a semi-quantitative metabolic signature of both analyzed cell lines. 13 of the identified 26 modified ribonucleosides were elevated in the cell culture supernatants of MCF-7 cells, with 5-methyluridine, N 2,N 2,7-trimethylguanosine, N 6-methyl-N 6-threonylcarbamoyladenosine and 3-(3-aminocarboxypropyl)-uridine showing the most significant differences. 1-ribosylimidazole-4-acetic acid, a histamine metabolite, was solely found in the supernatants of MCF-10A cells, whereas 1-ribosyl-4-carboxamido-5-aminoimidazole and S-adenosylmethionine occurred only in supernatants of MCF-7 cells. The obtained results are discussed against the background of pathological changes in cell metabolism, resulting in new perspectives for modified nucleosides and related metabolites as possible biomedical markers for breast carcinoma in vivo.Keywords
This publication has 59 references indexed in Scilit:
- 5 ′-Amino-4-Imidazolecarboxamide Riboside Induces Apoptosis in Human Neuroblastoma Cells Via the Mitochondrial PathwayNucleosides, Nucleotides and Nucleic Acids, 2006
- Mimicry of a Cellular Low Energy Status Blocks Tumor Cell Anabolism and Suppresses the Malignant PhenotypeCancer Research, 2005
- Urinary nucleosidesMass Spectrometry Reviews, 1998
- Structural characterization of modified nucleosides in tRNA hydrolysates by frit-fast atom bombardment liquid chromatography/mass spectrometryJournal of Mass Spectrometry, 1994
- Effect of mast cell products and histamine on the proliferative behaviour of human melanoma and carcinoma cells in vitroInflammation Research, 1993
- Demonstration of histamine H2 receptors on human melanoma cellsBiochemical and Biophysical Research Communications, 1988
- Isolation and Characterization of a Novel Nucleoside from the Urines of Chronic Myelogenous Leukemia PatientsNucleosides, Nucleotides and Nucleic Acids, 1987
- Stimulation of histamine synthesis from tumour cells by concanavalin A and A23187Inflammation Research, 1987
- Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1982
- Synthesis and properties of the naturally occurring N-[(9-β-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt6A) and other related synthetic analogsBiochemistry, 1975